Loading clinical trials...
Loading clinical trials...
Dushenne muscular dystrophy (DMD), which is characterized by the deficiency of dystrophin protein, prevents the muscle from maintaining its normal activity, causing progressive damage to the heart, respiratory muscles and skeletal muscles. When studies on patients with DMD are examined in the literature, very few studies are found investigating the effectiveness of pure respiratory muscle training, while no studies are found investigating the effectiveness of functional respiratory muscle training.
Age
5 - 17 years
Sex
MALE
Healthy Volunteers
No
Tepecik training and research hospital
Izmir, Konak, Turkey (Türkiye)
Start Date
May 1, 2024
Primary Completion Date
May 1, 2025
Completion Date
May 1, 2025
Last Updated
September 15, 2025
40
ACTUAL participants
Respiratory Muscle Training
OTHER
Lead Sponsor
Izmir Katip Celebi University
NCT07037862
NCT07160634
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06450639